Celladon

company

About

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

  • 11 - 50

Details

Industries
Biotechnology,Health Care,Hospital,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.